Cyclacel pharmaceuticals to release fourth quarter and full year 2022 financial results

Berkeley heights, n.j., feb. 27, 2023 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce fourth quarter and full year 2022 financial results on monday, march 6, 2023. the company will host a conference call at 4:30pm et on the same day.
CYCC Ratings Summary
CYCC Quant Ranking